Close
Nordic 9Nordic 9

General Inception (investor - Venture Capital)

United States generalinception.com
See something wrong or missing? Let us know
Offices:San Francisco

General Inception - GI is a venture studio incubator from kthe US that partners with scientific founders at or soon after company formation.

Average round investment:15M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: United Kingdom Constructive Bio
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to General Inception

Name Criteria
United Kingdom Emma Watson
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Arvind Gupta
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Alexander Moscho
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Lombardstreet Ventures
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Milad Alucozai
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland SAGANA
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Bosch Ventures
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
France Total Carbon Neutrality Ventures
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Netherlands DSM Venturing
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Syngenta Ventures
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top